Result:Poor· Market: Down
| Metric | Value (₹ Cr) | Q1 FY26 |
|---|---|---|
| Revenue | 1.02 | 4.8% |
| Total Income | 1.30 | 27.4% |
| Expenditure | 2.45 | 15.1% |
| PBT | -1.15 | 692.3% |
| Net Profit | -1.19 | 598.5% |
| OPM | — | |
| NPM | -91.26% | 81.77pp |
| EPS | 1.64 | 429.0% |
Pharma micro-cap posted a widening loss (NetProfit -1.19cr vs -0.17cr YoY) on declining revenue (-4.8% YoY), clear deterioration with no offsetting quality signal.
Informational and educational content only. Not investment advice.